A Clearinghouse for Information about Blood Clots (DVT/)PE) and Clotting Disorders (thrombophilia) provided as a public service by the University of North Carolina Blood Research Center

Category: Prevention

  • VTE Prophylaxis in Hospitalized Patients: Guidance Document

    Stephan Moll, MD writes (on 12/5/2014)… Venous thromboembolism (VTE) prophylaxis in hospitalized patients is important; it is also mandated by the Joint Commission [ref].  We have developed at the University of North Carolina (UNC) a guidance document (link here; UNC VTE prophylaxis guidance document) as a resource for our health care professionals to assist in…

  • Behind the headlines: Does eating lunch at your desk increase blood clot risk?

    Beth Waldron,  Program Director of Clot Connect, writes… The claim:  “Eating lunch at your desk could increase your risk of DVT”—was the dramatic headline from UK’s Marie Claire magazine which caught my attention. (1)  The online story went on to say that “Almost 75 per cent of office staff aged 21-30 who work 10-hour days…

  • VTE Prevention in Hospitalized Patients: New ACP Guideline

    A new guideline was published this week about venous thromboembolism (VTE) prophylaxis in hospitalized medical sick patients and in stroke patients [link here; ref 1]. The key points of this guideline,

  • Hip and Knee Replacement – DVT Prevention – New Guideline

    Two main guidelines exist which many physicians go by to decide whether a particular patient should get DVT prophylaxis after hip or knee replacement surgery, what method (compression device, or drug) to use, and for how long to give prophylaxis.  (a) One is the ACCP guideline (American College of Chest Physicians), last published in June 2008 [ref…

  • Hip and Knee Replacement Surgery – DVT Prophylaxis – AAOS Guideline

    Two main guidelines exist which many physicians go by to decide whether a particular patient should get DVT prophylaxis after hip or knee replacement surgery, what method (compression device, or pharmacologic agent) to use, and for how long to give prophylaxis.  (a) One is the ACCP guideline (American College of Chest Physicians), last published in June 2008…

  • Xarelto (Rivaroxaban) – FDA Approved

    Today the FDA approved the oral anticoagulant Xarelto (rivaroxaban) for DVT prevention in patients undergoing knee or hip replacement surgery.  This is good news

  • Xarelto (Rivaroxaban) – FDA Approved

    On July 1st, the FDA approved the oral blood thinner Xarelto (rivaroxaban) for the prevention of deep vein thrombosis (DVT) in patients undergoing  knee or hip replacement surgery.

  • Long Distance Travel and Blood Clots

    Background and Summary Long distance travel, either by plane, car, bus or train, is a slight risk factor for DVT (deep vein thrombosis) and PE (pulmonary embolism). The risk is low. However, there are some people who are at higher risk. In these people compression stockings and/or an injection of a low-dose “blood thinner” (low…